Hi Timothy,
Sorry for the confusion, I cut out a bit too much of my original post.
To clarify my point: there is evidence that suggests that the specific genotype of HBV may play a role in the clinical outcome and optimal treatment of Hepatitis B. It is, however, not always the case that genotyping is done and when it is done it does not always affect the initial treatment regimen the patient is put on, such as using interferon over entacavir.
On another note, I could only find the above references when looking into this. Would it be better to find a gap with a stronger foundation in research than this?
Thanks,
Scott